Virtual Tumor Board™: EGFR Mutation Matters: Optimizing Therapy by EGFR Mutation Subtype and Co-Mutations | Live CME

Virtual Tumor Board®: EGFR Mutation Matters: Optimizing Therapy…

Read the full article here

Source: www.gotoper.com
Categories: Hem/Onc News and Journals, Latest Headlines
Tags: , , ,
Tweets with this article
PER
Learn about the latest advances in mutational profiling to optimize therapy for patients with EGFR mutant NSCLC during this complementary webcast. Register now at https://t.co/NkMqaS9lhO #gotoPER #EGFR #NSCLC #lcsm https://t.co/foMYkKc75W

Related Articles